116 related articles for article (PubMed ID: 32379878)
21. Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
Kumar Mongre R; Sharma N; Singh Sodhi S; Ghosh M; Kumar Singh A; Kim N; Park YH; Shin YG; Kim SJ; Jiao Jiao Z; Huynh DL; Jeong DK
Biomed Pharmacother; 2017 Mar; 87():741-754. PubMed ID: 28110264
[TBL] [Abstract][Full Text] [Related]
22. The human and murine hematopoietic stem cell niches: are they comparable?
van Pel M; Fibbe WE; Schepers K
Ann N Y Acad Sci; 2016 Apr; 1370(1):55-64. PubMed ID: 26713726
[TBL] [Abstract][Full Text] [Related]
23. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
Bissig-Choisat B; Kettlun-Leyton C; Legras XD; Zorman B; Barzi M; Chen LL; Amin MD; Huang YH; Pautler RG; Hampton OA; Prakash MM; Yang D; Borowiak M; Muzny D; Doddapaneni HV; Hu J; Shi Y; Gaber MW; Hicks MJ; Thompson PA; Lu Y; Mills GB; Finegold M; Goss JA; Parsons DW; Vasudevan SA; Sumazin P; López-Terrada D; Bissig KD
J Hepatol; 2016 Aug; 65(2):325-33. PubMed ID: 27117591
[TBL] [Abstract][Full Text] [Related]
24. Patient-derived xenograft models of breast cancer and their predictive power.
Whittle JR; Lewis MT; Lindeman GJ; Visvader JE
Breast Cancer Res; 2015 Feb; 17(1):17. PubMed ID: 25849559
[TBL] [Abstract][Full Text] [Related]
25. Building avatar armies with fish and flies.
Neff EP
Lab Anim (NY); 2020 Apr; 49(4):101-104. PubMed ID: 32210417
[No Abstract] [Full Text] [Related]
26. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
[TBL] [Abstract][Full Text] [Related]
27. Visualizing Human Hematopoietic Stem Cell Trafficking In Vivo Using a Zebrafish Xenograft Model.
Staal FJ; Spaink HP; Fibbe WE
Stem Cells Dev; 2016 Feb; 25(4):360-5. PubMed ID: 26650921
[TBL] [Abstract][Full Text] [Related]
28. Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.
Chokshi C; Dhillon M; McFarlane N; Venugopal C; Singh SK
Methods Mol Biol; 2016; 1458():231-45. PubMed ID: 27581026
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic-Pharmacodynamic-Efficacy Modeling of ONO-7579, a Novel Pan-Tropomyosin Receptor Kinase Inhibitor, in a Murine Xenograft Tumor Model.
Iida H; Fujikawa R; Kozaki R; Harada R; Hosokawa Y; Ogawara KI; Ohno T
J Pharmacol Exp Ther; 2020 Jun; 373(3):361-369. PubMed ID: 32217770
[TBL] [Abstract][Full Text] [Related]
30. Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α.
Zheng BN; Ding CH; Chen SJ; Zhu K; Shao J; Feng J; Xu WP; Cai LY; Zhu CP; Duan W; Ding J; Zhang X; Luo C; Xie WF
Theranostics; 2019; 9(9):2606-2617. PubMed ID: 31131056
[No Abstract] [Full Text] [Related]
31. Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression.
Qin J; Liu Y; Lu Y; Liu M; Li M; Li J; Wu L
Sci Rep; 2017 Sep; 7(1):10592. PubMed ID: 28878214
[TBL] [Abstract][Full Text] [Related]
32. Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines.
Miwa T; Kanda M; Umeda S; Tanaka H; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
In Vivo; 2019; 33(6):1785-1792. PubMed ID: 31662503
[TBL] [Abstract][Full Text] [Related]
33. Development and Applications of Patient-Derived Xenograft Models in Humanized Mice for Oncology and Immune-Oncology Drug Discovery.
Verma B; Ritchie M; Mancini M
Curr Protoc Pharmacol; 2017 Sep; 78():14.41.1-14.41.12. PubMed ID: 28892144
[TBL] [Abstract][Full Text] [Related]
34. Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia.
Tasian SK; Kenderian SS; Shen F; Ruella M; Shestova O; Kozlowski M; Li Y; Schrank-Hacker A; Morrissette JJD; Carroll M; June CH; Grupp SA; Gill S
Blood; 2017 Apr; 129(17):2395-2407. PubMed ID: 28246194
[TBL] [Abstract][Full Text] [Related]
35. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells.
Lin B; Chen T; Zhang Q; Lu X; Zheng Z; Ding J; Liu J; Yang Z; Geng L; Wu L; Zhou L; Zheng S
Oncotarget; 2016 Nov; 7(47):77495-77507. PubMed ID: 27769048
[TBL] [Abstract][Full Text] [Related]
36. Transgenic strategies to generate heterogeneous hepatic cancer models in zebrafish.
Fei F; Wang L; Sun S; Lv K; Yao Y; Wang J; Yu M; Wang X
J Mol Cell Biol; 2019 Dec; 11(11):1021-1023. PubMed ID: 31370058
[No Abstract] [Full Text] [Related]
37. Head and neck cancer patient-derived xenograft models - A systematic review.
Schuch LF; Silveira FM; Wagner VP; Borgato GB; Rocha GZ; Castilho RM; Vargas PA; Martins MD
Crit Rev Oncol Hematol; 2020 Nov; 155():103087. PubMed ID: 32992152
[TBL] [Abstract][Full Text] [Related]
38. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models.
Tang Z; Ma H; Mao Y; Ai S; Zhang P; Nie C; Gao Y; Lu R
Exp Cell Res; 2019 Jun; 379(1):110-118. PubMed ID: 30935947
[TBL] [Abstract][Full Text] [Related]
39. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.
Chen X; Li Q; Liu X; Liu C; Liu R; Rycaj K; Zhang D; Liu B; Jeter C; Calhoun-Davis T; Lin K; Lu Y; Chao HP; Shen J; Tang DG
Clin Cancer Res; 2016 Sep; 22(17):4505-16. PubMed ID: 27060154
[TBL] [Abstract][Full Text] [Related]
40. Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma.
Welker AM; Jaros BD; An M; Beattie CE
Neuroscience; 2017 Jul; 356():35-43. PubMed ID: 28526577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]